Feasibility RCT of ACT Self-help for Depression in Haemodialysis
NCT ID: NCT02565056
Last Updated: 2016-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2015-01-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Self-Compassion Online - Preventing Depression Trial
NCT04350814
Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis
NCT00618475
Organized Self-Management Support Services for Chronic Depression
NCT01139060
Augmented Human Intelligence in Major Depressive Disorder
NCT04355650
A Helping Hand Among Low-Income Patients
NCT02147522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is estimated that depression is experienced by 20-40% of people with ESRD. Depression not only affects the quality of life of individuals with ESRD but is also associated with higher rates of hospitalisation and poorer physical health outcomes.
Acceptance and Commitment Therapy (ACT) has been found to be an effective treatment for depression and has been used successfully as a self-help treatment. However, no study has examined the effectiveness of an ACT self-help treatment for depression in ESRD. This study aims to assess the feasibility of conducting such a study and will look at suitability of recruitment, assessment methods and the acceptability of the self-help treatment, as well as helping to calculate the number of people needed for a definitive study.
Haemodialysis patients receiving dialysis through an NHS renal service will be invited to participate. To participate they will be consenting, over 18 years of age and experiencing depressive symptoms at a clinical level. Those eligible will be randomly assigned into one of two conditionsÍž a control condition receiving treatment as usual (TAU), and an intervention condition receiving TAU alongside an ACT self-help manual with weekly telephone support. The manual will be completed over six weeks. Both groups will be asked to complete questionnaires prior to intervention and 2 and 4 months post-intervention. Participants from each condition will be asked to participate in interviews to explore their experiences of taking part.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-help
Self-help book completed over 6 weeks with up to 30 minutes of telephone support per week.
Self help book + telephone support
Self-help book based upon principles of Acceptance and Commitment Therapy
Treatment as usual
Treatment as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self help book + telephone support
Self-help book based upon principles of Acceptance and Commitment Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving haemodialysis treatment for more than 6 months
* moderate depression (as indicated by the PHQ-9)
Exclusion Criteria
* lacking mental capacity to consent due to cognitive impairment
* inadequate reading ability (indicated by inability to complete PHQ-9 screening measure)
* visual or hearing impairment that would prevent completion of the self-help book or engagement in telephone calls
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nottingham University Hospitals NHS Trust
OTHER
University of Lincoln
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Vogt
Trainee Clinical Psychologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Vogt, MSc, BSc
Role: PRINCIPAL_INVESTIGATOR
University of Lincoln
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shipley Dialysis Unit, Ilkeston Community Hospital
Ilkeston, Derbyshire, United Kingdom
Mike Cassidy Dialysis Unit, Kings Mill Hospital
Mansfield, Nottinghamshire, United Kingdom
Main Dialysis Unit & Centenary Dialysis Unit (same site), City Hospital
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
156756
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.